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1. Introduction 
The fact that living organisms play a key role on health, was put on a scientific basis at the 
beginning of the last century by Elie Metchinikoff,  when working at the Pasteur  Institute in 
Paris. The findings that Bulgarian peasants, who ingested large amounts of soured milks, also 
lived to a ripe old age led him to conclude about the beneficial effects of fermented milks.  
One of the most convincing demonstrations of the role of the gut microbiota in resistance to 
disease was provided by Collins and Carter [1]. These authors proved that germ-free 
guinea–pig was killed by 10 cells of Salmonella Enteritidis, but it required 109 cells to kill a 
conventional animal with a complete gut microbiota. 
Probiotic was initially defined by Parker [2] as “Organisms and substances which 
contributes to intestinal microbial balance”. Fuller [3] redefined probiotics as “A live 
microbial feed supplement which beneficially affects the host animal by improving its 
intestinal microbial balance”. This definition clarifies the need for a probiotic to be viable. 
The term prebiotic was subsequently adopted to define “non-digestible food ingredients 
that beneficially affect the host by selectively stimulating the growth and/or activity of one 
or a limited number of bacteria in the colon that improve host health”[4]  Modification by 
prebiotics of the composition of the colonic microbiota leads to the predominance of a few of 
the potentially health-promoting bacteria, especially, but not exclusively, lactobacilli and 
bifidobacteria.  Much of the work on prebiotics deals with the use of oligosaccharides, 
although the first demonstration of this type of effect was observed with a disaccharide, 
lactulose. Gibson and Roberfroid [4] also launched the concept of symbiotic by combining 
the rationale of pro- and prebiotics, is proposed to characterize some colonic foods with 
interesting nutritional properties that make these compounds candidates for classification as 
health-enhancing functional food ingredients.  
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The bacterial genera most often used as probiotics are lactobacilli and bifidobacteria. At 
present, probiotics are almost exclusively consumed as fermented dairy products such as 
yogurt or freeze-dried cultures, but in the future they may also be found in fermented 
vegetables and meats [5]. 
The microbial community inhabiting the gastrointestinal tract is characterized by its high 
population density, wide diversity, and complexity of interactions. Bacteria are predominant 
but a variety of protozoans, yeasts and bacteriophages are also found. Bacteria are not 
distributed randomly throughout the gastrointestinal tract but instead are found at population 
levels and species distributions that are characteristic of specific regions of the tract. The 
stomach and proximal small intestine contain relatively low numbers of microorganisms. 
Acid- tolerant lactobacilli and streptocococci predominate in the upper smal intestine. The 
distal small intestine (ileum) maintains a more diverse microbiota and higher bacterial 
numbers. The large intestine (colon) is characterized by large numbers of bacteria, low redox 
potential, and relatively high short-chain fatty acid concentrations. The prominent role played 
by anaerobic bacteria in this dynamic ecosystem is evident from the finding that more than 
99% of the bacteria isolated from human fecal specimens are anaerobic or aerotolerant [6].  
The intestinal tract is a dynamic ecosystem that is influenced by host, intrinsic, and 
environmental factors. Thus, our undestanding of gut microbial interactions and how the 
gastrointestinal activity is modulated, might help on establishing screening criteria to 
identify potentially probiotic bacteria suitable for human or animal use.  
2. Microbial interactions in the gut 
The nature of the microbial interaction can be predominantly by competition or mutualism 
[7]. In the gut they can affect either the population level of a given strain or the metabolic 
activity of that strain. In addition, genetic transfers can occur between strains within the gut. 
The host and the diet cam modulate the expression of the microbial interactions. These 
interactions involve multiple mechanisms that are poorly understood. Such mechanisms are 
involved either in the size of subdominant microbial populations or in the metabolic 
activities of predominant populations. Diet and perhaps other environmental factors, such 
as stress, can modify their expression. 
The gastrointestinal tract of neonates becomes colonized immediately after birth with 
environmental microorganisms, mainly from the mother by several processes including 
sucking, kissing, and caressing. The proximity of the birth canal and the anus, as well as 
parental expression of neonatal care, are effective methods of ensuring transmission of 
microbes from one generation to the next [6].The pattern and level of exposure during the 
neonatal period is likely to influence the microbial succession and colonization in the 
gastrointestinal tract. Infants from developing countries have an early colonization with 
enterobacteria whereas those born in countries with good obstetric and hygienic procedures, 
may result in a delayed  development pattern or even  the absence of certain groups of 
intestinal bacteria during succession [8].  
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After the birth process, neonates are continuously exposed to new microbes that enter the 
gastrointestinal tract with food. This begins with breast milk, which contains up to 106 
microbes/mL in healthy mothers. The most frequently encountered bacterial groups include 
staphylococci, streptococci, corynebacteria, lactobacilli, micrococci, propionibacteria and 
bifidobacteria originated from the nipple and surrounding skin as well as the milk ducts in 
the breast [6, 9, 10]. 
A pronounced dominance of bifidobacteria was observed over the entire breast-feeding 
period, with a corresponding reduction in facultative bacteria [11, 12]. There is a strong 
evidence suggests that the early composition of the microbiota of neonates plays an 
important role for the postnatal development of the immune system [13, 14].  
Both adults and neonates are regularly exposed to microorganisms via the diet, but are 
affected differently. The microorganisms entering newborns via milk are more likely to 
colonize than are those entering healthy adults [6, 15]. 
Bacterial species or strains that will be established in the infant bowel might be capable to 
utilize the substrates provided by the diet and the particular human host. Bifidobacteria, E. 
coli and enterococci can utilize a wide range of monosaccharides and oligosaccharides which 
would be provided by the diet. Once established the range of fermentable substrates 
available to the bacteria changes from mono and oligosaccharides to complex plant 
polymers (dietary fibre) that pass undigested through to the small bowel. The other major 
complex carbohydrates is provided by the mucins that are continuously secreted into the 
bowel by the goblet cells present in the mucosal lining.  Strict regulations of catabolic  
pathways must be an extremely important attribute in a habitat where the nutritional profile 
will vary from day to day according to the omnivorous and varied dietary preferences of the 
human host and help [16] 
Protection against colonization of the intestinal tract by potentially pathogenic 
microorganisms, due to the gut microbiota, was called competitive exclusion [17], whose 
pioneering evidence had been obtained by Nurmi and Rantala [18], with birds. When these, 
soon after birth, were inoculated with cecal material of an adult bird, the frequency of 
Salmonella infections was significantly reduced. 
Undoubtedly the main benefit attributed to probiotics is the competitive exclusion of 
pathogens that occurs by different mechanisms including: a) competition for receptors in the 
intestinal epithelium as occurs with lactobacilli that directly inhibits the binding of 
Salmonella, E. coli and other foodborne pathogens b) secretion of factors that inhibit 
internalization and adhesion of pathogens, as well as increased secretion of mucin as with 
lactobacilli which stimulate the secretion of MUC2 and MUC3 2 which inhibits the 
adherence of enteropathogenic E. coli c) stimulating the mucosal barrier effect, such as the 
lactobacilli and bifidobacteria which helps to prevent pathogens from inducing an increase 
in intestinal permeability; d) production of volatile fatty acids and / or other antibacterial 
substances, by the anaerobic microbiota besides nutrient competition [19, 20]. 
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Constituents of the normal microbiota and some pathogenic bacteria have the ability to 
colonize the mucosal surfaces [21] Some microorganisms seem to be able to securely attach 
to the intestinal epithelium [22], and is thought to be this an important prerequisite for 
probiotics in a long-term survival during competition against other microorganisms for 
specific niches and subsequent multiplication. However, no consensus among researchers 
exists about the fact that a probiotic should or should not adhere to mucosal surfaces, 
colonize and then exert a probiotic effect, being an alternative its regular consumption to 
maintain the levels needed to promote the effect, forming a transient microbiota [23]. 
Another desired effect of a probiotic includes altered metabolism of the intestinal microbiota 
as the reduction in the synthesis of toxins or carcinogenic substances or an  increased 
production of short-chain fatty acids or other substances that improve the condition of the 
mucosa. Prebiotics may also be given to augment immune reaction, preferably those that 
have a protective effect without causing overt inflammation . The ability of lactic bacteria to 
inactivate mutagenic compounds, such as dyes and N-nitrosamines, has been attributed to 
cell wall components, such as peptidoglycan and polysaccharides [24].. The lactic acid 
bacteria also may mediate anticarcinogenic activities by reducing the activity of fecal 
bacterial enzymes such as nitroredutases, azoredutases and  glucuronidase (EC 3.2.1.31) 
that convert procarcinogenic to  carcinogenic compounds in the colon [14] 
The ability to sense other bacteria may have important consequences for competitive and 
nutritional strategies controlling for example, entry into stationary phase, dispersal and the 
production of antimicrobial compounds. The ability to interfere with the signalling of 
bacteria will determine the fitness of the given organism to survive in the gut and may also 
have therapeutic potential. The study of cell-to-cell communication in gastrointestinal(GI) 
tract bacteria is not as advanced as it is for bacteria from other ecosystems. In Gram-negative 
bacteria the best-characterized systems involve N-acylhomoserine lactone (acyl-HSL) 
signals, LuxI family signal synthases and LuxR family response regulators. It appears that 
Gram-positive bacteria prefer peptide signals, also termed peptide pheromones [25]. 
Probiotics may play an active role inflammatory bowel diseases by enhancing the intestinal 
barrier at the mucosal surface. Caballero-Franco et al. [26] investigated whether the clinically 
tested VSL#3 probiotic formula and/or its secreted components could augment the protective 
mucus layer in vivo and in vitro. For in vivo studies, Wistar rats were orally administered the 
probiotic mixture VSL#3 on a daily basis for seven days. After treatment, basal luminal mucin 
content increased by 60%. In contrast to the animal studies, cultured cells incubated with 
VSL#3 bacteria did not exhibit increased mucin secretion. However, the bacterial secreted 
products contained in the conditioned media stimulated a remarkable mucin secretion effect. 
Among the three bacterial groups (Lactobacilli, Bifidobacteria, and Streptococci) contained in 
VSL#3, the Lactobacillus species were the strongest potentiator of mucin secretion in vitro. 
The competitive exclusion of pathogens mediated by lactobacilli is usually performed by 
two mechanisms: (i) production of antimicrobial substances such as lactic acid and 
bacteriocins, and (ii) adhesion to the mucosa and coaggregation which can form a barrier 
which prevents colonization by pathogenic microorganisms [27]. 
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Three mechanisms of aggregation have been reported so far. The first is related to the 
interaction between the components of the cell surface, as in the oral cavity with 
Streptococcus sanguis and Prevotella locscheii in which adhesins are protein-type lectins. 
Adlerberth et al. [28] observed that the adhesion of Lactobacillus plantarum to human colonic 
cells HT-29 was due to mannose-sensitive attaching mecanism. As the cell walls of the yeast 
Saccharomyces cerevisiae consists polysaccharide containing mannose (mannans), Escherichia 
coli and other enterobacteria containing mannose-specific adhesin receptors agglutinate 
yeast cells. The ability of binding yeast cells may therefore be an indication of mannose 
specific activity [29]. 
Autoaggregation has been correlated with adhesion, which is known to be a prerequisite for 
colonization and infection of the gastrointestinal tract by many pathogens. Adherence to the 
epithelium is therefore a prerequisite for enterotoxigenic Escherichia coli both to colonize the 
small intestine and to cause diarrhea, since adherence targets toxins directly onto the 
epithelial cell [30]. 
Coaggregation is a process by which genetically distinct bacteria become attached to one 
another via specific molecules. Cumulative evidence suggests that such adhesion influences 
the development of complex multi-species biofilms. The coaggregation properties of 
probiotic strains with pathogens as well as their ability to displace pathogens are of 
importance for therapeutic manipulation of the aberrant intestinal microbiota. Aggregation 
abilities of a probiotic with the pathogen strains were strain-specific and dependent on time 
and incubation conditions [31] 
Recently, the complement protein mannose-binding lectin (MBL) has been shown to play a 
role in the first line of defense against Candida albicans. MBL binds to a wide variety of 
microorganisms through a carbohydrate recognition domain, exhibiting strong binding to 
Candida and other yeast species. The complement system is activated via this lectin pathway, 
causing opsonization and direct lysis of microorganisms[32]. A number of probiotic bacteria 
contact recognition proteins, including lectins, enzymes and other factors involved in 
carbohydrate metablolism , are involved in microbe-microbe host interactions [33].  
In other cases, the adhesins are not lectins, such as in the case of Streptococcus sanguis and 
Streptococccus gordonii [34]. 
The second mechanism, described in lactobacilli, is dependent upon secretion of a protein of 
32 kDa  that promotes aggregation and  a high frequency of conjugation [35] According to  
Collado,  Meriluoto and  Salminen [31] the ability to autoaggregate, together with cell-
surface hydrophobicity and coaggregation abilities with pathogen strains can be used for 
preliminary screening in order to identify potentially probiotic bacteria suitable for human 
or animal use.  
Finally, in Enterococcus faecalis, the ability to promote aggregation is due to secretion of small 
hydrophobic peptides called sex pheromone with consequent increase of the frequency 
combination [36, 37]. Pheromones appear to induce the synthesis surface proteins encoded 
by the plasmid, which mediate cell-cell contact.The sex pheromone system of Enterococcus 
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faecalis is responsible for the clumping response of a plasmid carrying donor strain with a 
corresponding plasmid free recipient strain due to the production of sex pheromones by the 
recipient strain. The clumping response is mediated by a surface material (called 
aggregation substance) which is synthesized upon addition of sex pheromones to the 
cultures. After induction a dense layer of hairlike  structures is formed on the cell wall of 
the bacteria that are  responsible for the cell-cell contact which leads to the aggregation of 
cells [38] 
Boris et al. [39] have characterized a peptide produced by Lactobacillus gasseri (previously 
classified as plantarum), which promotes the aggregation of cells of L. plantarum and 
Enterococcus spp. The authors hypothesize that these aggregates could mediate protection of 
the mucosa by the formation of a bacterial film that prevents access of undesirable 
microorganisms in the vaginal mucosa. 
3. Bioactive prebiotic components in milk 
Many components of human milk are multifunctional, providing antimicrobial, 
antiinflammatory, antioxidant effect besides being growth factors [40]. 
Breast milk not only provides a range of substrates for bacterial growth, but it also appears 
to be a reservoir for some of the bacteria we inherit, including Lactobacillus sp. and 
Bifidobacteria [41] Breast milk contains viable lactobacilli and bifidobacteria that might 
contribute to the initial establishment of the microbiota in the new born  [10]. Although this 
needs to be verified and an explanation given with mechanism uncovered as to how 
lactobacilli reach the mammary gland and if other bacteria do likewise, the end result is that 
infants are colonized predominantly by lactic acid bacteria [20]. 
Although it is likely that antimicrobial components in human milk inhibit the growth of 
pathogenic bacteria, it is also likely that some substances stimulate the growth of beneficial 
bacteria, ie, they have prebiotic activity. This factor, originally called the bifidus factor, may 
promote the growth of Lactobacilli and Bifidobacteria, which can limit the growth of several 
pathogens by decreasing intestinal pH. One possible substance identified was N-acetyl-
glucosamine [42]. Subsequently, several oligosaccharides have been shown to have this 
activity, but it is also possible that milk proteins also have such prebiotic activity . Increasing 
the lactobacilli and bifidobacteria levels is a target for infant formulas and the most common 
approach to this end has been to include prebiotic compounds [10]. 
The gut microbiota of breastfed infants is different from that of formula-fed infants. 
According to Penders [43], exclusively formula-fed infants were more often colonized with 
E coli, C difficile, Bacteroides, and lactobacilli, compared with breastfed infants. Although 
Penders et al. [44] showed that formula-fed infants have similar counts of bifidobacteria 
compared with breast-fed infants, most reports found that breast-fed infants have higher 
number of bifidobacteria, whereas formula-fed infants develop a mixed flora with a lower 
level of bifidobacteria [45]. 
 
Microbial Interactions in the Gut: The Role of Bioactive Components in Milk and Honey 405 
Oliveira [12] studied the influence of diet and type of delivery in 68 neonates aged between 
seven and 21 days on both composition and evolution of the gut Bifidobacterium spp., 
Lactobacillus spp. microbiota. Gut colonization by bifidobacteria was not influenced by the 
type of delivery but the counts of lactobacilli were higher in those born vaginally as shown 
in table 1. Lactobacilli numbers in infants fed formula and human milk and born vaginally 
were significantly higher (p<0.05) than those born by caesarean, suggesting a possible 
microbiota transference from mother to the child. Similar results were reported by Biasucci 
[46] that demonstrated significant retarded colonization by lactobacilli at 10 days of age in 
babies delivered by cesarean section. Differently, Martin et al. [47] found that lactic acid 
bacteria colonization was not significantly related to the delivery method. 
Oliveira [12] also found that bifidobacteria numbers in infants born vaginally and fed with 
breast milk (BM) were higher than the others, while those who received pasteurized human 
milk from  milk  banks  (HMB) showed a significant lower number of Bifidobacterium as 
compared to other types of feeding (Table 1). No significant differences were observed on 
infants born by cesarean. These in vivo results corroborate with previously, in vitro observed 
data, by Borba and Ferreira [48], who evaluated the effect of  human milk pasteurization on 
growth of different species of Bifidobacterium. It was demonstrated that pasteurization of 
human milk affected the growth of bifidobacteria, indicating that, somehow, the 
pasteurization process (65°C/30minutos) inhibits bifidogenic factors, or results in the 
production of inhibitory compounds to this microbial group 
The same negative pasteurization effect was observed by Oliveira [12] on the growth of 
lactobacilli (Table 1). Although breast-milk contains viable lactobacilli and bifidobacteria 
that might contribute to the initial establishment of the microbiota in the newborn, the 
negative effect of human milk pasteurization on the lactobacilli and bifidobacteria gut 
population, cannot be explained solely on the destruction of those bacteria by the 
pasteurization process. Milk formulas do not contain these bacteria, but favored the 
development of bifidobacteria and lactobacilli in the intestine reaching a number 
significantly higher, as compared to the gut microbiota of pasteurized human milk fed 
infants. 
Indeed, the health-promoting effects of breast-milk have been linked partly to the presence 
of lactobacilli and bifidobacteria in breast-milk [10, 47], but clearly also to different milk 
bifidogenic components. 
Both lactotobacilli and bifidobacteria benefit in environments with low redox potential and 
the presence of antioxidant compounds present in human milk. Anti-oxidants such as 
lactoferrin, α-tocopherol, β carotene, cysteine, ascorbic acid, uric acid, catalase and 
glutathione peroxidase are present in human milk [40]. Most of these compounds are 
thermo-labile and might have been destroyed during milk pasteurization process. Whey 
protein is rich in cysteine, the thermo-labile amino acid which represents an effective cysteine 
delivery system for the cellular synthesis of glutathione. In addition, the ability of cysteine 
and cysteine to lower redox potential stimulates de growth of anaerobic or anaero-tolerant 
bacteria. The repeated processes that donor human milk is submitted before delivery to 
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newborn infants cause a reduction in the fat and protein concentration. The magnitude of 
this decrease is higher on the fat concentration and it needs to be considered when this 
processed milk is used to feed preterm infants [49]. 
 
 Cesarean Vaginally 
 Lactobacillus  
HMB 2,4 a A 3,3 b A 
FM 2,8 a B 5,7 a A 
BM 3,8 a B 5,6 a A 
Bifidobacterium 
HMB 5,6 a A 3,7 b A 
FM 5,7 a A 6,5 ab A 
BM 6,2 a A 7,4 a A 
Treatments with the same small letters in columns and capital letters in rows do not differ significantly by Tukey test 
(P> 0.05) 
Table 1. Averages of the Lactobacilli and Bifidobacteria log numbers, in babies born by cesarean section 
and vaginally delivery, fed with pasteurized  milk  from human milk  banks  (HMB), formula (FM) and 
breast milk (BM). 
3.1. Milk oligosaccharides 
For many years, the oligosaccharides were considered for his role in the modulation of 
intestinal microbiota of infants. Currently, there is strong evidence that free oligosaccharides 
as well as glycoproteins are potent inhibitors of bacterial adhesion on the surface of the 
epithelium in the early stages of the infectious process. Therefore, the milk oligosaccharides 
have two important functions. The first as a source prebiotic stimulating the growth of 
probiotic bacteria and a second, operating in a non-specific defense mechanism inhibiting 
pathogens from adhering to the gastrointestinal mucosa. Although the exact 
pathophysiological mechanism of diarrhea is not yet fully elucidated, it seems that the 
ability of microorganisms to adhere to the mucosal surface is essential for spreading 
diarrheagenic bacteria in the duodenum [50]. 
Concentrations of total oligosaccharides in human milk (HMO) is 5,0-8,0 g per liter whereas 
just traces are found in cow’s milk.  In cow’s milk, only small amounts of oligosaccharides 
are detectable, with sialyllactose being the major component [51].  
Differences in the qualitative or quantitative aspects of term and preterm milk have not been 
observed, but compositional changes of oligosaccharides in term milk occurs during 
lactation with the largest amounts being found at early stages. The highest concentrations of 
HMOs can be found in colostrum (20 g/L), but even mature milk contains oligosaccharides 
in concentrations up to 13 g/L [52]. Coppa [11] reported that  lactose concentration (±SD) in 
human milk  increased from 56 ± 6.06 g/L on day 4 to 68.9 ± 8.16 g/L on day 120. 
Oligosaccharide level decreased from 20.9 ± 4.81 g/L to 12.9 ± 3.30 gIL, respectively. 
Monosaccharides represented only 1.2% of total carbohydrates.  
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Although intact HMOs may be absorbed, ENGFER et al. [52] postulate that a majority of 
HOs reach the large intestine, where they serve as substrates for bacterial metabolism. 
Therefore, HMOs might be considered the soluble fiber fraction of human milk 
Human milk compared with other milk species, is considered unique in terms of its 
complex oligosaccharides content. With few exceptions, HMOs have a core structure 
consisting of a lactose unit at the reducing end linked to N-acetyllactosamine units (type 1 
and 2), with branching occurring frequently Residues of L-fucose, sialic acid [N-
acetylneuraminic acid (NeuAc), or both can be found linked to the core without further 
elongation. An elongation is achieved by an enzymatic attachment of GlcNAc residues 
linked in ß1-3 or in ß1-6 linkage to a Gal residue followed by further addition of Gal in a 
ß-1-3 or ß-1-4 bond. Thus, a large number of core structures can be formed. Further 
variations occur due to the attachment of lactosamine, Fuc, and/or NeuAc residues at 
different positions of the core region and of the core elongation chain (10, 50). The 
addition of Fuc is dependent on the actions of at least three different fucosyltransferases 
in a genetically determined process.[51, 52].. 
Within human milk oligosaccharides at least 10 containing GlcNAc are known as  growth 
factors for a so-called bifidus biota in breastfed infants. Dietary modulation of the intestinal 
microflora is today one of the main topics of interest in the nutritional sciences. Fructo-
oligosaccharides (FOS) and galacto-oligosaccharides (GOS) are prebiotics whose bifidogenic 
activity has been proven in adults. Moro and Arslanoglu [19] demonstrated that 
supplementation of infant formulas with a mixture of GOS and FOS modified the fecal flora 
of term and preterm infants, stimulating the growth of Bifidobacteria. In the trial with term 
infants, the bifidogenic effect of the prebiotic mixture was dose dependent and there was 
also a significant increase in the number of Lactobacilli in the supplemented group. 
The similarities between epithelial cell surface carbohydrates and oligosaccharides in 
human milk strengthen the idea that specific interactions of those oligosaccharides with 
pathogenic microorganisms do occur preventing the attachment of microbes to epithelial 
cells. HMOs may act as soluble receptors for different pathogens, thus increasing the 
resistance of breast-fed infants. Some of the best-characterized adhesins of bacteria are those 
of E. coli, which possesses type 1 fimbriae (mannose sensitive), S fimbriae (sensitive to 
sialylated galactosides), or colonization factors [a heterogeneous group with various 
receptor specificities. The various ligand specificities of E. coli strains could explain the 
differences in intestinal colonization of breastfed versus formula-fed newborns: The free 
oligosaccharides and glycoproteins of human milk, which are present in large amounts and 
great variety, might prevent intestinal attachment of microorganisms by acting as receptor 
analogs competing with epithelial ligands for bacterial binding [51] 
Rockova et al. [53] reported that two strains of B. animalis were unable to grow on a medium 
containing human oligosaccharides as the sole carbon source in contrast of bifidobacteria 
from human origin. On the other hand human oligosaccharides seem to be more specific for 
human origin bifidobacteria compared with fructooligosaccharides. Hence, new prebiotics 
with similar bifidogenic properties like human oligosaccharides should be developed. 
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3.2. Milk proteins 
Whey proteins constitute about 60-80% of the total protein content of human milk, but only 
18% of bovine milk.  Furthermore, the composition of whey proteins is different for each of 
the milks: beta-lactoglobulin, that is not found in human milk, predominates in bovine milk, 
while alfalactalbumin and lactoferrin predominate in human milk. The alfalactalbumin is 
necessary for the synthesis of lactose in the mammary gland, through the action of the 
lactose synthetase enzyme, their concentration in human milk ranges from 0.22 to 0.46 g/dl. 
The betalactoglobulin has been blamed for allergies to bovine milk [54]. 
Undenatured whey protein is rich in cysteine, the thermo-labile amino acid which represents 
an effective cysteine delivery system for the cellular synthesis of glutathione. Both cysteine 
and glutamine, along with glycine, are necessary the synthesis of the tri-peptide glutathione 
(GSH), one of the major detoxifiers (Phase II sulfonation) and antioxidants of the body. 
Enhancing glutathione levels also helps reduce the risk of infections by improving white 
blood cell functions. However, the unique disulfide cystine bonds of whey are heat sensitive 
(thermo-labile) so only carefully processed, undenatured whey proteins deliver bioavailable 
cystine di-peptides for intracellular conversion to cysteine, thus maximizing glutathione 
levels with its important immune, antioxidant, and detoxification benefits. [55].  
3.2.1. Lactoferrin 
Whey proteins present in human milk, such as secretory IgA, lactoferrin and lysozyme are 
very stable in acid medium, and reasonably resistant the action of proteolytic enzymes, it is 
believed, therefore, that over three quarters of these proteins appear intact in the feces of 
infants. Approximately 6-10% of lactoferrin is not digested by the intestinal tract, assuming 
that it can reach the colon and play prebiotic activities [56] 
Lactoferrin, a glyco-protein, is a major protein in human milk (1.3-2.8 g/L) while it is present 
only in traces in cow´s milk. Lactoferrin inhibits the growth of bacteria and fungi due to its 
ability to bind iron, a function known as ferro-privation. Iron is a nutrient usually required for 
bacterial growth. In this way the effect of lactoferrin can be ascribed to an inhibitory effect 
against a pathogens rather than a direct stimulus to the development of Bifidobacteria [11]. 
In addition, lactoferrin also promotes the growth of beneficial bacteria such as L. bifidus, 
helping infants establish good microbial conditions in their intestines, described as 
“eubiosis”. It is also an antioxidant that naturally occurs in many body secretions such as 
tears, blood, breast milk, saliva and mucus. Lactoferrin has anti-viral, anti-tumor activity, 
anti-infl ammatory / anti-oxidant activity, and immuno-modulating activity [57] Lactoferrin 
is also a cystine rich sub fraction. 
3.2.2. Lisozime 
Lysozyme is an antimicrobial enzyme (EC 3.2.1.17) found in tears, saliva, human milk whey, 
mucus, neutrophil granules and egg- white. It hydrolyses b (1,4) linkage between N 
acetylglucosamine and N-acetylmuramic acid in bacterial cell wall. Gram positive bacteria 
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are more susceptible to lysozyme than Gram negative. The enzyme synergistically interacts 
with other immunoprotective components like IgA, C3 complement components and 
lactoferin. Human milk contains up to 400 mg/mL of lysozyme, which is a concentration 
approx. 3000 times higher than in bovine milk.[58] 
Resistance to lysozyme and the ability to utilize human milk oligosaccharides (HMOs) 
were identified as the most important factors affecting the growth of bifidobacteria in 
human milk. Four out of 5 strains of human origin were resistant to lysozyme and 
utilized HMOs. In contrast, B. animalis was susceptible to lysozyme and did not utilize 
HMOs [53] 
According to Rockova et al. [58] the lysozyme-resistant Bifidobacterium bifidum and 
Bifidobacterium longum strains exhibited excellent growth in human milk. In contrast, most of 
non-indigenous species, such as C. butyricum, did not grow in human milk oligosaccharides 
together with lysozyme may act as prebiotic-bifidogenic compounds inhibiting intestinal 
clostridia. 
3.2.3. Lactoperoxidase 
Lactoperoxidase makes up approximately 0.5% of the whey protein. In the presence of 
hydrogen peroxide (formed in small quantities by cells), catalyzes the oxidation of 
thiocyanate (part of saliva), forming hypothiocyanate, which can kill both gram-positive 
and gram-negative bacteria. Thus, lactoperoxidase in human milk may contribute to the 
defense against infection already in the mouth and upper gastrointestinal tract. Human 
milk contains active lactoperoxidase, but its physiologic significance is not yet 
known.[42] 
3.2.4. κ-Casein and glycomacropeptide 
κ-Casein, a minor casein subunit in human milk, is a glycoprotein with charged sialic acid 
residues. The heavily glycosylated k-casein molecule has been shown to inhibit the 
adhesion of Helicobacter pylori to human gastric mucosa. K-Casein has been shown to 
prevent the attachment of bacteria to the mucosal lining by acting as a receptor analogue 
[42]. 
Glycomacropeptide is resultant from the tryptic hydrolysis of human k-casein, containing 
sugars glucosamine and galactosamine. The molecular weight of intact human k-casein was 
estimated to be approximately 33,000. The human k-casein contained about 40% 
carbohydrate (15% galactose, 3% fucose, 15% hexosamines, and 5% sialic acid) and 0.10% (1 
mol/mol) phosphorus. Its amino acid composition was similar to that of bovine k-casein 
except for serine, glutamic acid, and lysine contents [59] 
Glycomacropeptide helps control appetite and inhibit the formation of dental plaque and 
dental cavities. It is a growth factor for bifidobacteria (bifidogenic factor 1) Levels of 
glycomacropeptide may range from 1% to 18% [40] 
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3.3. Milk fat 
The main fatty acids present in human milk are restricted to those with 12-18 carbon atoms 
chains,namely lauric, myristic, palmitic, palmitoleic, stearic, oleic, linoleic and linolenic. 
Some of the long chain polyunsaturated acids such as arachidonic  and others are derived 
from essential fatty acids linoleic and linolenic acids, totaling together with their precursors, 
about 15% of fat of human milk. This percentage is much higher than that found in bovine 
milk. Palmitic, oleic and linoleic add up together about 70% of total fatty acids of colostrum 
and 74% of that of mature milk [54] 
Corcoran et al. [60] studied the effect of inclusion of various C18 fatty acids with 0–2 double 
bonds in either cis or trans configuration on Lactobacillus rhamnosus GG survival in simulated 
gastric juice at pH 2.5. Overall, the data suggest that probiotic lactobacilli can use an 
exogenous oleic acid source to increase their acid survival and the underlying mechanism 
most likely involves the ability of increased membrane oleic acid to be reduced by H+ to 
stearic acid.  
Rosberg-Cody et al. [61] isolate different strains of the genus Bifidobacterium from the 
fecal material of neonates and assessed their ability to produce the cis-9, trans-11 
conjugated linoleic acid (CLA) isomer from free linoleic acid. The most efficient 
producers belonged to the species Bifidobacterium breve, of which two different strains 
converted 29 and 27% of the free linoleic acid to the cis-9, trans-11 isomer per microgram 
of dry cells, respectively. In addition, a strain of Bifidobacterium bifidum showed a 
conversion rate of 18%/μg dry cells. The ability of some Bifidobacterium strains to produce 
CLA could be another human health-promoting property linked to members of the 
genus, given that this metabolite has demonstrated anticarcinogenic activity in vitro and 
in vivo. 
4. Bioactive prebiotic components in honey 
Most of the honey in the world is produced by bees from the nectar. Nectar is a sugar 
solution and water, may contain pure sucrose, a mixture of sucrose, glucose and fructose, or 
glucose and fructose only. The nectar is transported to the combs of the hive, where they 
will undergo physical and chemical changes responsible for their maturation (Crane, 1983). 
The chemical composition of honey, as well as aroma, color and medicinal properties, are 
directly related to the nectar source that originated with the bee species that produced it, 
with their geographic and climatic conditions. All these factors contribute to the wide 
variation found in honey [62]. 
Shin and Ustunol [63] defines honey as natural syrup containing mainly fructose (38.5%) 
and glucose (31.3%). Other sugars in honey include maltose (7.2%), sucrose (1,5%) and a 
variety of oligosaccharides (4.2%). In addition to the complex mixture of carbohydrates, are 
enzymes, minerals, pigments, waxes and pollen. More than one hundred eighty substances 
have been found in different honey types. 
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Honey is a complex product of easy digestion and assimilation, constituting a source of 
energy that contributes to the balance of biological processes in that it contains suitable 
proportions, enzymes, vitamins, fatty acids, amino acids, phenolic and aromatic substances 
[64]. In addition contains oligosaccharides which stimulates the growth of probiotic bacteria 
in the gut [65, 66]. 
Leite et al. [65], found in various di-and trisaccharides in Brazilian honeys. Maltose showed 
up in higher levels in honeys surveyed followed by other five disaccharides, turanose, 
nigerose, melibiose, sucrose, isomaltose and four trisaccharides, maltotriose, panose, 
melezitose and raffinose.. 
Cellobiose, gentiobiose, isomaltose, kojibiose, laminaribiose, maltose, maltulose, melibiose, 
nigerose, palatinose, trehalose, trehalulose, turanose, and sucrose are the main disaccharides 
found in honey [66, 67]. However, it would be rather difficult to identify the predominant 
disaccharide or certain combinations in the previously studied honey types. For example, 
maltulose and turanose were found in many honey samples, however their concentrations 
varied to a wide extent. Thus, Sanz and others [66] found the highest amounts of maltulose 
and turanose (0.66 to 3.52 and 0.72 to 2.87 g/100 g of honey, respectively) in 10 samples of 
honey from different regions of Spain and commercially available nectar and honeydew 
honeys. 
Carbohydrate degradation has been extensively studied in a variety of different 
Bifidobacterium species. Various α- and β-galactosidases, α- and β-glucosidase and β-
fructofuranosidases during growth on fructooligosaccharides activities have been 
characterized in Bifidobacterium species. Additionally, starch-, amylopectin-, and pullulan-
degrading activities in bifidobacteria have been investigated [68] 
Pokusaeva et al. [68] describe the identification of two genes, agl1 and agl2, present in the 
genome of B. breve UCC2003 and responsible for the hydrolysis of α-glycosidic linkages, 
such as those present in palatinose. The preferred substrates for both enzymes were panose, 
isomaltose, and trehalulose. The two purified α-1,6-glucosidases were also shown to have 
transglycosylation activity, synthesizing oligosaccharides from palatinose, trehalulose, 
trehalose, panose, and isomaltotriose. 
Proline is the main amino acid present in honey; it is added by the bee and its amount varies 
depending on the floral source.[67]. 
Macedo et al. [69] studied the effect of the Apis mellifera honey on growth and viability of 
commercial strains of lactobacilli and bifidobacteria in fermented milk. Milk was inoculated 
with 2% of each probiotic separately and added with 3% of honey. After fermentation, were 
stored at 7 º C for up to 46 days and were evaluated periodically. The honey did not affect 
the growth or activity of lactobacilli, but exerted significant positive effect (p<0.05) on 
Bifidobacterium cultures assisting in maintaining the viability and stimulating metabolic 
activity of these bacteria, with increased pH reduction. 
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5. Conclusion 
It is well stablished the role of several oligosaccharides as prebiotic substances. The prebiotic 
effect of human milk, however, is not related to a single growth-promoting substance, but 
rather to a complex of interacting factors. In particular the prebiotic effect has been ascribed 
to several oligosaccharides, that is clearly proved. The role and the way milk fat and 
proteins such as lactoferrin, lysozyme stimulate the growth of probiotic bacteria is not yet 
clearly defined.  
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